 |
ArticleArticle-The Pandemic’s Impact on Over-the-Counter Cough and Cold Product Innovation |
As the consumer health industry emerges from a slowdown in innovation due to the pandemic, Catalent Consumer Health keeps a close watch on the global market to identify key trends, innovation opportunities, and performance across categories. In this article, Catalent experts examine how the pandemic has impacted cough and cold products innovation, and what this means for the market.
Learn more about:
The effect of COVID-19 on over-the-counter upper respiratory product launches
Top companies and brands in the OTC cough and cold space
Vitamins, minerals, and supplements (VMS) innovations landscape in the cough and cold market.
Why Catalent?
Catalyst + Talent
Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply over 70 billion doses of more than 7,000 products to over 1,000 customers annually. Catalent’s expert workforce exceeds 17,000, including more than 2,500 scientists and technicians. Headquartered in Somerset, New Jersey, the company generated $4 billion in revenue in its 2021 fiscal year. For more information, visit www.catalent.com.
More products. Better treatments. Reliably supplied.™
